Various analytic methods and model specifications confirm that the intercept (i.e., starting point) and the slope (i.e., direction of change) are different between the pre-and post-periods. We characterized a polypharmacy sub-population of Premera BlueCross members and performed a program evaluation to assess the effects of a safety-focused, educational, mail-based intervention for persons identified with multiple chronic medication claims.
• Pre-period and post-period self-control design.
• Limited knowledge of direct participation.
• Mail order inclusion required a Rx count algorithm.
• Analysis did not evaluate changes in dose or adherence.
• There was no data on health outcome effects. 
Select Evaluation Limitations
Evaluation used pharmacy and medical claims data from Premera data sources. Demographic, membership, and eligibility data were also used. 126 (1.108, 1.144 ) ; adj. 1.129 (1.111, 1.147) . Hosp: unadj. 1.169 (1.152, 1.187) ; adj. 1.166 (1.148, 1.184 ).
Members' pharmacy and medical claims were characterized and a pre-intervention and post-intervention analysis compared monthly medication frequencies and safety-related medical events (emergency room (ER) visits and hospitalizations) for the two, one-year periods.
General linear mixed models (GLMM) were used to test for time-period differences in prescriptions. The top ICD-9 codes for ER visits and hospitalizations, as well as the most frequently used medications were reported. GLMM applied to monthly medications indicated significant differences in the mean number of monthly medications at period start and in the slope of monthly medication trends during the periods. ER visits and hospitalizations (safety-related events) were reduced by roughly 1% in the post-period (23% to 22%; 13% to 12%, respectively; both p<0.0001). Used pharmacy and medical claims data (2 years) and basic demographic information to describe these members.
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